Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on October 12, 2005
J Am Soc Nephrol 16: 3680-3686, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2005040382

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2005040382v1
16/12/3680    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gregorini, G.
Right arrow Articles by Scolari, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gregorini, G.
Right arrow Articles by Scolari, F.
Related Collections
Right arrowRelated Article

Clinical Nephrology

Renal Apolipoprotein A-I Amyloidosis: A Rare and Usually Ignored Cause of Hereditary Tubulointerstitial Nephritis

Gina Gregorini*, Claudia Izzi*, Laura Obici{dagger}, Regina Tardanico{ddagger}, Christoph Röcken§, Battista Fabio Viola*, Mariano Capistrano*, Simona Donadei{dagger}, Luciano Biasi||, Tiziano Scalvini, Giampaolo Merlini{dagger} and Francesco Scolari*

* Division of Nephrology, {ddagger} Pathology Department, || Division of Infectious Diseases, and Department of Internal Medicine, Spedali Civili, Brescia, Italy; {dagger} Amyloid Center, Biotechnology Research Laboratories, IRCCS San Matteo, Pavia, Italy; and § Department Pathology, Otto von Guericke University of Magdeburg, Magdeburg, Germany

Address correspondence to: Dr. Francesco Scolari, Cattedra e Divisione di Nefrologia, Università e Spedali Civili, Piazza le Spedali Civili 1, Brescia 25125, Italy. Phone: +39-030-3995628; Fax: +39-030-3995012; E-mail: fscolar{at}tin.it

Received for publication April 11, 2005. Accepted for publication August 22, 2005.

Apolipoprotein A-I amyloidosis is a rare, late-onset, autosomal dominant condition characterized by systemic deposition of amyloid in tissues, the major clinical problems being related to renal, hepatic, and cardiac involvement. Described is the clinical and histologic picture of renal involvement as a result of apolipoprotein A-I amyloidosis in five families of Italian ancestry. In all of the affected family members, the disease was caused by the Leu75Pro heterozygous mutation in exon 4 of apolipoprotein A-I gene, as demonstrated by direct sequencing and RFLP analysis. Immunohistochemistry confirmed that amyloid deposits were specifically stained with an anti-apolipoprotein A-I antibody. The clinical phenotype was mainly characterized by a variable combination of kidney and liver disturbance. The occurrence of renal involvement seemed to be almost universal, although its severity varied greatly ranging from subclinical organ damage to overt, slowly progressive renal dysfunction. The renal presentation was consistent with a tubulointerstitial disease, as suggested by the findings of defective urine-concentrating capacity, moderate polyuria, negative urinalysis, and mild tubular proteinuria. Histology confirmed tubulointerstitial nephritis. Surprising, amyloid was restricted to nonglomerular regions and limited to the renal medulla. This location of apolipoprotein A-I amyloid differs sharply from other systemic amyloidoses that are mainly characterized by glomerular and vascular deposits. The tubulointerstitial nephritis as a result of hereditary apolipoprotein A-I amyloidosis is a rare disease and a challenging diagnosis to recognize. Patients who present with familial tubulointerstitial nephritis associated with liver disease require a high index of suspicion for apolipoprotein A-I amyloidosis.


Related Article

This Month’s Highlights
J. Am. Soc. Nephrol. 2005 16: 3447-3448. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
T. Scalvini, P. R. Martini, A. Gambera, R. Tardanico, L. Biasi, F. Scolari, G. Gregorini, and E. Agabiti Rosei
Spermatogenic and Steroidogenic Impairment of the Testicle Characterizes the Hereditary Leucine-75-Proline Apolipoprotein A-I Amyloidosis
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1850 - 1853.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
S. M. Korbet and S. Bonsib
A Case of Polyneuropathy and Proteinuria
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 624 - 636.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. Bergesio, A. M. Ciciani, M. Santostefano, R. Brugnano, M. Manganaro, G. Palladini, A. M. D. Palma, M. Gallo, P. L. Tosi, M. Salvadori, et al.
Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis
Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1608 - 1618.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
L. M. Dember
Amyloidosis-Associated Kidney Disease
J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3458 - 3471.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP